Filing
Spy
Filing
Spy
Home
About
AKBA
Akebia Therapeutics Inc
Biopharmaceutical company
CUSIP: 00972D105
Healthcare
US
2 holders
Ownership
Activity
Fundamentals
2020 Q2
4 of 11 quarters
Total Value
$280.51M
Total Shares
20.66M
Net Share Change
-2.53M
Activity
1 selling
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$203.70M
15.00M
2.5%
TRIM
-2.53M
(-14.4%)
Baupost Group LLC
$203.70M
15.00M shares
TRIM
-2.53M
(-14.4%)
Abrams Capital Management
$76.81M
5.66M
2.5%
Unchanged
Abrams Capital Management
$76.81M
5.66M shares
Unchanged
AKBA — Akebia Therapeutics Inc - FilingSpy